Newtag icon
Top Black Friday 2025 brands announced! What were the hottest products and categories?Download the report now 👉banner icon
Prevail

November 2025

Prevail Market Share Analysis for November 2025

Ask Us Anything.
Year Founded--
Employees51 - 200
Annual Revenue$5M - $10M
prevail.com
Prevail
Prevail (including company regionals)
  • prevail.com
    prevail.com
See more website traffic and engagement information

Prevail Revenue up to November 2025 is 5M - 10M

revenue generated by Prevail top domains

Prevail top domains revenue over 3 years

Revenue for Prevail top domains


Total visits to Prevail's top domains

Understand Prevail market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Prevail's top domains

Analyze Prevail engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Prevail's top domains

See how Prevail keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Prevail

These are the website technologies, by industry, used by Prevail top domains

Advertising (6)

Google Adsense

Google Adsense

Conversion & Analytics (5)

Google Analytics

Google Analytics

Audio Video Media (4)

YouTube

YouTube

Marketing (4)

Google Marketing Platform

Google Marketing Platform

More Technologies

7

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Prevail

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPrevail is developing CRISPR-based genetic medicines for neurological and neuromuscular indications on May 23rd '23.Tuesday, Jennifer Doudna-founded Scribe Therapeutics and Eli Lilly subsidiary Prevail entered into a strategic collaboration to develop CRISPR-based genetic medicines for neurological and neuromuscular indications.

See all Prevail signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.